End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.2 BGN | 0.00% | +1.31% | +8.39% |
May. 30 | Sopharma AD Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 29 | Sopharma AD Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | 1.99B 1.11B | Sales 2025 * | - | Capitalization | 1.11B 617M |
---|---|---|---|---|---|
Net income 2024 * | 72M 40.02M | Net income 2025 * | - | EV / Sales 2024 * | 0.56 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
13.5
x | P/E ratio 2025 * |
-
| Employees | 4,721 |
Yield 2024 * |
4.84% | Yield 2025 * |
-
| Free-Float | 30.85% |
1 day | -0.32% | ||
1 week | +1.31% | ||
Current month | -0.96% | ||
1 month | +4.03% | ||
3 months | -4.02% | ||
6 months | -13.17% | ||
Current year | +8.39% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Director of Finance/CFO | - | 01-12-31 | |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 40 | 00-09-30 | |
Bisera Lazarova
BRD | Director/Board Member | - | - |
Director/Board Member | 61 | 99-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 6.2 | 0.00% | 3 220 |
24-06-05 | 6.2 | -0.32% | 52,658 |
24-06-04 | 6.22 | +0.32% | 1,042,126 |
24-06-03 | 6.2 | -0.96% | 1,845 |
24-05-31 | 6.26 | +1.95% | 6,741 |
End-of-day quote Bulgaria S.E., June 04, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+8.39% | 617M | |
-38.95% | 13.75B | |
-32.10% | 10.8B | |
-10.85% | 7.31B | |
+10.79% | 6.19B | |
-11.53% | 5.89B | |
+73.65% | 4.79B | |
-4.09% | 4.58B | |
-8.36% | 3.75B | |
-19.80% | 3.14B |
- Stock Market
- Equities
- SFA Stock